SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024973
Filing Date
2021-05-06
Accepted
2021-05-06 16:13:16
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20210331.htm   iXBRL 10-Q 2614830
2 EX-31.1 dvax-ex311_8.htm EX-31.1 17833
3 EX-31.2 dvax-ex312_12.htm EX-31.2 17774
4 EX-32.1 dvax-ex321_9.htm EX-32.1 6085
5 EX-32.2 dvax-ex322_11.htm EX-32.2 6327
  Complete submission text file 0001564590-21-024973.txt   10192832

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dvax-20210331.xsd EX-101.SCH 67580
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20210331_cal.xml EX-101.CAL 66583
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20210331_def.xml EX-101.DEF 268702
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20210331_lab.xml EX-101.LAB 524261
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20210331_pre.xml EX-101.PRE 423379
11 EXTRACTED XBRL INSTANCE DOCUMENT dvax-10q_20210331_htm.xml XML 2028844
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 21897909
SIC: 2834 Pharmaceutical Preparations